营养支持疗法在治疗慢性肺心病急性加重期并发呼吸衰竭的临床应用

目的:观察营养支持疗法在治疗慢性肺心病急性加重期并发呼吸衰竭的临床疗效。方法:将61例呼吸衰竭患者随机分成对照组30例和治疗组31例。对照组给予常规抗感染、氧疗、酸碱失衡及纠正电解质紊乱治疗;而治疗组除上述治疗外,加用营养支持治疗,按需求给予补充能量、维生素及微量元素,疗程2周。治疗前后查体重、血清白蛋白、淋巴细胞计数及动脉血气分析。结果:治疗组患者治疗后其体重、血清白蛋白、淋巴细胞计数较治疗前明显上升(P<0.05);对照组患者上述指标虽也上升,但P>0.05。治疗组PaCO2下降21.3±3.32mmHg,与对照组相比P<0.05,与治疗前相比P<0.01。治疗组平均住院天数及综合住院费用均较对照组低。结论:营养支持疗法在治疗慢性肺心病急性加重期并发呼吸衰竭中有重要作用,对纠正呼吸衰竭有良好疗效,能缩短住院日,降低住院费用,减轻病人负担。

Objectlve：To observe the effectiveness of nutrition supportive therapy inacute exacerbation and respiratory failure of chronic pulmonary heartdisease. Method：61 cases of respiratory failure were randomly divided into two groups, the comparative group 30and the treatment group 31. Both groups were provided with common fora treatment period of two weeks. The comparative group was treated with regular anti - infection, oxygen therapy, acid - base disturbance and correction of electrolyte disorder, while the treatment group was added with nutrition supportive therapy, including energy, multi -vitamins and microelements based on individual demand. After the treatment, both groups were subject to the following examinations, including weight, blood albumin, lymphocytecount and arterial bloodgas. Result ： After treatment, the treatment group obtained an obvious increase in their weights, blood albumins and lymphocyte counts. The comparative group also obtained certain increase, but the. In addition, the PaCO2 of the treatment group decreased by 21.3± 3.32mmHg. The comparing with the comparative group, the aftertreatments. Averagely, the patients of treatment group spent fewertimeand lower expensesin the hospital. Conclusion：The nutrition supportive therapy plays great importance in acute exacerbation and respiratory failure of chronic pulmonary heart disease. It can greatly ease respiratory failure, shorten the time spending in hospital, reduce clinic expenses and lower the burden of the patient.